DMD Digital Health Connections Group Inc
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloi… Read more
DMD Digital Health Connections Group Inc (APTOF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.381x
Based on the latest financial reports, DMD Digital Health Connections Group Inc (APTOF) has a cash flow conversion efficiency ratio of 0.381x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.41 Million) by net assets ($-19.45 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DMD Digital Health Connections Group Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how DMD Digital Health Connections Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
DMD Digital Health Connections Group Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DMD Digital Health Connections Group Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Magellan Gold Corp
PINK:MAGE
|
0.000x |
|
Woodbois Limited
PINK:WODBF
|
N/A |
|
Royal Prima PT
JK:PRIM
|
0.002x |
|
Zonte Metals Inc
PINK:EREPF
|
-0.004x |
|
Polar Power Inc
NASDAQ:POLA
|
0.141x |
|
Altshuler Shaham Financial LTD
TA:ALTF
|
-0.209x |
|
Farmaceutica R
RO:RMAH
|
N/A |
|
Lianhe Sowell International Group Ltd Ordinary Shares
NASDAQ:LHSW
|
N/A |
Annual Cash Flow Conversion Efficiency for DMD Digital Health Connections Group Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of DMD Digital Health Connections Group Inc from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-4.54 Million | $-35.98 Million | 7.919x | -48.48% |
| 2023-12-31 | $-2.90 Million | $-44.59 Million | 15.371x | +1894.75% |
| 2022-12-31 | $37.74 Million | $-32.32 Million | -0.856x | -46.82% |
| 2021-12-31 | $74.24 Million | $-43.30 Million | -0.583x | -315.87% |
| 2017-12-31 | $21.54 Million | $5.82 Million | 0.270x | +48.67% |
| 2016-12-31 | $17.91 Million | $3.25 Million | 0.182x | -61.79% |
| 2015-12-31 | $10.30 Million | $4.90 Million | 0.476x | +123.52% |
| 2014-12-31 | $-1.56 Million | $3.16 Million | -2.023x | -72.51% |
| 2013-12-31 | $-3.10 Million | $3.64 Million | -1.173x | -- |